Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 15

Difference in Gastrointestinal Risk Associated with Use of GLP-1 Receptor Agonists: A Real-World Pharmacovigilance Study

Total article views   HTML views PDF downloads Totals
10,725 Dovepress* 6,870+ 530 7,400
PubMed Central* 3,855 432 4,287
Totals 10,725 962 11,687
*Since 13 January 2022
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 0 4

View citations on PubMed Central and Google Scholar